Shoulder Innovations Inc SI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Shoulder Innovations Announces Closing of up to $50 Million Credit Facility
-
Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
-
Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook
-
Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem
-
Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026
Trading Information
- Previous Close Price
- $21.23
- Day Range
- $19.85–21.30
- 52-Week Range
- $10.92–22.92
- Bid/Ask
- $16.45 / $22.88
- Shares Outstanding
- 20.74M
- Market Cap
- $418.08M
- Volume/Avg
- 62,646 / 105,113
Key Statistics
- Price/Earnings (Normalized)
- 60.82
- Price/Sales
- 3.44
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 75
Valuation
|
Metric
|
SI
|
|---|---|
Price/Earnings (Normalized) | 60.82 |
Price/Book Value | 3.32 |
Price/Sales | 3.44 |
Price/Cash Flow | — |
Price/Earnings
SI
Financial Strength
|
Metric
|
SI
|
|---|---|
Quick Ratio | 9.65 |
Current Ratio | 11.81 |
Interest Coverage | — |
Quick Ratio
SI
Profitability
|
Metric
|
SI
|
|---|---|
Return on Assets (Normalized) | −33.33% |
Return on Equity (Normalized) | −75.48% |
Return on Invested Capital (Normalized) | −60.80% |
Return on Assets
SI
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|pP%!<# | LOCK|#<r<c | $164B | |||
| Stryker Corp
SYK
| LOCK|#MFNwK%d | LOCK|Z>$ | $126B | |||
| Medtronic PLC
MDT
| LOCK|&#&SS<d | LOCK|L$NZn | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|<qH?Sf | LOCK|G?ZK> | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|&#p?#W< | LOCK|t!X?P | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|?mB#<&T | LOCK|$^D | $29B | |||
| DexCom Inc
DXCM
| LOCK|&y@F@lk | LOCK|l$QG^ | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|YP | LOCK|z? | $27B | |||
| Steris PLC
STE
| LOCK|bwl%Y$C | LOCK|%%%#n | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|B?c<!F? | LOCK|Xt | $18B |
United States